Figure 6
(A) Inhibition zones observed for Ag–Cu NPs and Ampicillin (at concentrations ranging from 15 to 120 µg mL–1) against P. aeruginosa and S. aureus. (B) Mechanism of action underlying the antibacterial activity of Ag–Cu nanoparticles (NPs).
Figure 6 | Scientific Reports
